Final Thoughts: Improving QoL in Multiple Sclerosis
Optimistic Outlook in Treating Multiple Sclerosis
Patient Support Networks for Multiple Sclerosis
OPTIMUM Trial for Multiple Sclerosis
TRIUMPHANT-MS Trial for Multiple Sclerosis
Multiple Sclerosis Fatigue
Quality of Life Issues: Cognitive Changes with MS
Patient’s Journey of Therapies for Multiple Sclerosis
Treatment Options Available for Multiple Sclerosis
Managing Psychological Symptoms of Multiple Sclerosis
Areas of Need in Epilepsy Research: Barbara Jobst, MD
The director of the Dartmouth Epilepsy Program provided an overview of some of the critical unmet needs within ongoing epilepsy research following the recent AES Annual Meeting.
FAME Study: Partial-Onset Seizures
Raising the Importance of Deep Sleep in Cognitive Care: Christian Agudelo, MD
The Evelyn F. McKnight Neurocognitive Scholar at the University of Miami Miller School of Medicine provided thoughts on why cognitive care and sleep disorder care should crossover more often.
Supporting Patients With Parkinson Disease During COVID-19: James Beck, PhD
The chief scientific officer of the Parkinson’s Foundation discussed strategies to close the gap between household income and telehealth use.
Psychological Impact of Multiple Sclerosis
AUPN Leadership Minute Episode 6: Chair Faculty Evaluations
Episode 6 of the AUPN Leadership Minute features Mud M Alvi, MD, of West Virginia University and Robert C. Byrd Health; and David G Standaert, MD, PhD, of University of Alabama at Birmingham. [WATCH TIME: 4 minutes]
AASM’s Strong Recommendation for Cognitive Behavioral Therapy: Jennifer Martin, PhD
The AASM board of directors member and professor of medicine at UCLA discussed some strengths of CBT.
Benefits to Data-Based Registries in ALS: James Berry, MD, MPH
The director of the Massachusetts General Hospital ALS Care Center spoke on the importance of data-based registries and how they can grow ALS research.
The Future of Managing Multiple Sclerosis
Managing Parkinson Disease Despite Motor and Nonmotor Challenges: Stewart Factor, DO
The director of the Parkinson’s Disease and Movement Disorder Program at Emory University School of Medicine explained the various factors that make Parkinson so difficult to manage.
Overarching Highlights from AES 2020: Barbara Jobst, MD
The director of the Dartmouth Epilepsy Program discussed a few of the notable highlights and themes from the recently completed American Epilepsy Society Annual Meeting.
Answer ALS’s Campaign Opens Door to Increased Data Access: James Berry, MD, MPH
The director of the Massachusetts General Hospital ALS Care Center discussed the origins of ‘The Data is Here’ campaign and the reason to launch it now.
FDA Grants BREN-02 Orphan Drug Designation, Memory Preservation in Primary Progressive Aphasia, Phenotypes of MS
Neurology News Network for the week ending January 30, 2021.
Preventing While Treating Acute Migraines: Richard B. Lipton, MD
The director of the Montefiore Headache Center discussed his hopes that rimegepant will be approved as a preventive treatment of migraine.
A Rational Approach to Assessing SMA Therapies: Julie Parsons, MD
The primary investigator of the phase 4 RESPOND study discussed the role that postmarketing studies can play in assessing treatments for SMA.
Institutionalizing Change for EEG Education in Residency Programs: Fabio Nascimento, MD
The clinical fellow at Massachusetts General Hospital gives his call to action on how what needs to change to improve EEG education among residency programs.
Improving Outcomes in Patients With Early Onset NMOSD: Gabrielle Macaron, MD
The neurologist from Cleveland Clinic discussed how her team found that patients with AO ≤21 years old had worse visual outcomes than those >21 years old.
Phase 4 RESPOND Trial and the Need for Similar Trials in SMA: Julie Parsons, MD
The primary investigator of RESPOND discussed the trial’s goals and measures, as well as insight into why clinical trials like it are important in spinal muscular atrophy.
Cognitive Risks Correlated With Lack of Sleep: Christian Agudelo, MD
The Evelyn F. McKnight Neurocognitive Scholar at the University of Miami Miller School of Medicine provided background on a recently completed study correlating sleep and cognitive decline.
Fumarates for Treatment of RMS
